Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Anzupgo (delgocitinib) Cream for the Treatment of Chronic Hand Eczema
BALLERUP, Denmark, July 23, 2025 – LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration...
Palliative Care or Hospice? What's the Distinction?
SATURDAY, July 26, 2025 — If a doctor diagnoses you with a serious illness and suggests palliative care, don’t jump to conclusions.It doesn’t mean...
Mental Health Care Use, Mortality Rates Increased With Prolonged Grief
Relatives bereaved by natural death with high and sustained grief symptoms have increased mental health care use and mortality for up to 10 years after...
'Forever Chemicals' Identified in Reusable Feminine Hygiene Products
Reusable feminine hygiene products often contain per- and polyfluoroalkyl substances (PFAS), according to a study published online July 22 in Environmental...
U.S. to Remove Mercury Preservative From Flu Jabs
FRIDAY, July 25, 2025 — It's official: The controversial preservative thimerosal will be stripped from all flu vaccines distributed in the United...
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Suboptimal Dialysis Initiation Common in Patients With Advanced CKD
Suboptimal dialysis initiation, typically defined as dialysis initiation during a hospitalization and/or with a central venous catheter, is common among...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Ritz Update: FDA Issues Risk Warning Due to Undeclared Peanuts in Some Cracker Sandwiches
FRIDAY, July 25, 2025 — Ritz peanut butter cracker sandwiches are being recalled due to the possible presence of undeclared peanuts, a major...
Lab Experiments Show Why Wrinkles Form
THURSDAY, July 24, 2025 — The struggle to tame wrinkles is an age-old conflict, with people using any number of lotions, creams and treatments to...
Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer
(BUSINESS WIRE)--Jul. 24, 2025-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK...
Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
Pierre Fabre Pharmaceuticals Inc. (PFP) announces the acceptance by U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA)...
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide...
Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies,...
Johnson & Johnson Seeks First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
SPRING HOUSE, Pa. (July 21, 2025) – Johnson & Johnson (NYSE: JNJ) today announced the submission of a New Drug Application (NDA)...
Recently Added
Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Anzupgo Anzupgo (delgocitinib) is a topical pan-Janus kinase (JAK) inhibitor for the treatment of chronic hand eczema.
- Kirsty Kirsty (insulin aspart-xjhz) is a rapid acting human insulin analog interchangeable biosimilar to NovoLog (insulin aspart) indicated to...
- Ekterly Ekterly (sebetralstat) is an oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema attacks in adults and...